FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and is a method of treating a human patient with lysosomal acid lipase (LAL) deficiency, comprising administering to a patient an effective amount of a recombinant glycoprotein of human lysosomal acid lipase (rHGLAL), wherein the rHGLAL consists essentially of an amino acid sequence selected from a group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:19, with N-glycans associated with asparagine (Asn) residues, which correspond to Asn36, Asn101, Asn161, Asn273 or Asn321 sequence SEQ ID NO: 1, provided that the N-glycans do not contain fucose, and provided that the rGLCH does not contain O-glycans, and where the N-glycans associated with Asn residues correspond to Asn36, Asn101, Asn161, Asn273 and Asn321 sequence SEQ ID NO: 1.
EFFECT: invention provides higher clinical effectiveness in the patient suffering lysosomal acid lipase deficiency.
10 cl, 30 dwg, 6 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| TOBACCO PROTEASE GENES | 2015 |
|
RU2756102C2 |
| GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 | 2020 |
|
RU2815545C2 |
| NPP1 FUSION PROTEINS | 2011 |
|
RU2760943C2 |
| NEW THERMOSTABLE PHYTASES WITH HIGH CATALYTIC EFFICIENCY | 2018 |
|
RU2758271C2 |
| MICROORGANISMS FOR PRODUCING ORNITHINE AND METHOD OF PRODUCING ORNITHINE USING SAID MICROORGANISMS | 2016 |
|
RU2721852C1 |
| OPTIMIZED POLYPEPTIDE FOR A SUB-UNIT VACCINE FOR REOVIRUS OF BIRDS | 2017 |
|
RU2742250C2 |
| MICROORGANISMS PRODUCING L-VALINE, AND METHOD OF PRODUCING L-VALINE USING SAME | 2021 |
|
RU2822660C1 |
| USE OF GLYCOSIDASES IN OLIGOSACHARIDE PRODUCTION | 2019 |
|
RU2810730C2 |
| FUSED MOLECULES DERIVED FROM CHOLIX-TOXIN FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE LOADS | 2015 |
|
RU2723178C2 |
